Multicentric Database for KRAS Mutant Pancreatic Cancer

Recruiting now

Conditions studied: Pancreatic Cancer

In brief

Construction and Maintenance of a Precision Subtyping-Based Clinical Cohort for Targeted Therapy in KRAS-Mutant Pancreatic Cancer

Key facts

Study ID

NCT07557849

Run by

Fudan University

People needed

1000

Starts

2026-05-22

Expected to finish

2029-04-30

Last updated by the study team

2026-05-26

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• No restrictions on age, gender, or performance status score;
• Pathologically or cytologically confirmed pancreatic adenocarcinoma; ③ Known KRAS mutation subtype and has received treatment with KRAS-targeted agents;
• ④ Able to comply with the study visit schedule requirements;
• ⑤ Voluntarily participate and sign the informed consent form.

You may not qualify if…

• Non-neoplastic pancreatic lesions;
• Non-primary pancreatic neoplastic lesions; ③ Unable to comply with the study visit schedule requirements; ④ Refuse to participate and sign the informed consent form.

Where it is running

• Department of Pancreatic Surgery — Shanghai, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.